Stevanato Group is set to commence construction on its new $145m manufacturing facility in Fishers, Indiana in the US, this month.
Planned to be competed in 2023, the site will provide an additional supply source for the firm’s mission critical products while allowing it to better serve North America pharmaceutical customers.
Go deeper with GlobalData
Expected to be up to 370,000ft2, the new facility will also support the expansion and production of Stevanato’s EZ-Fill solutions, pre-sterilised drug containment systems for pharmaceutical use.
The plant will comprise production lines featuring advanced process technologies to produce EZ-Fill syringes and vials.
Stevanato said it plans to use the new facility as a centre for after-sales support to serve its North American engineering customers.
The facility will also allow the firm to offer technical support as well as maintenance for visual inspection, assembly and packaging equipment.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataStevanato Group CEO Franco Moro said: “We are thrilled to begin construction on our new US hub, and expand our presence in one of the fastest growing markets where we see increasing demand.
“We believe this will allow us to further enhance our services to our valued North America customers and underscores our desire to ensure supply chain security, just in time delivery and reliable sourcing in terms of surge capacity.”
The facility is expected to create more than 230 jobs in production, engineering and maintenance, as well as other corporate support positions by the end of 2025.
Stevanato said that the plant would be part of a new pharmaceutical and life sciences park in Fishers.
———————————————————————————————————————-
The facility is expected to create more than 230 jobs. Credit: Giomar Arang/Pixabay.
